Post by DanMcQ on Nov 29, 2006 2:32:19 GMT -5
Excellent hire for the Med School:
November 27, 2006
The Georgetown University Community
Ladies and Gentlemen:
With great pleasure, I write to announce the appointment of Howard J. Federoff, M.D., Ph.D., as Executive Vice President for Health Sciences and Executive Dean of the School of Medicine, effective April 1, 2007. Dr. Federoff will be a frequent presence on campus over the course of the coming months, immersing himself in the transition to ensure that he is well acquainted with the Medical Center community and Medical Center operations and in a position to offer the most effective leadership possible when his term formally begins.
Dr. Federoff currently holds appointments as Senior Associate Dean for Basic Research; Professor of Neurology, Medicine, Microbiology, and Immunology; and Professor of Oncology and Genetics at the University of Rochester School of Medicine, and as Founding Director of the Center for Aging and Development Biology at the Aab Institute of Biomedical Sciences at Rochester. Since joining the Rochester faculty in 1995, he has also served as Director of the University of Rochester’s Interdepartmental Neuroscience Program and as Founding Chief of the Division of Molecular Medicine and Gene Therapy. His research interests include gene therapy and neurodegenerative diseases, and he holds a number of medical patents with a number of other patents pending. He brings to our community a strong record of leadership in academic medicine and achievement in biomedical research and an imaginative vision for the future of medical education and research at Georgetown—in traditional areas of strength and in the possibilities for interdisciplinary collaboration, translational research, and building further synergies with our clinical partner, MedStar Health, Inc.
Dr. Federoff is a highly regarded scientist, whose research has received support from the National Science Foundation, the National Institutes of Health (NIH), the Canadian MRC Centers of Excellence Program in Neuroscience, and the U.S. Department of Defense, among other sources. He has published widely in peer-reviewed journals and currently serves on the editorial boards of five such journals, including Brain and Mind, Experimental Neurology, and Gene Therapy. Earlier this year the NIH named Dr. Federoff Chair of the Recombinant DNA Advisory Committee. Before joining the Rochester community, he was Associate Professor of Medicine and Neuroscience at Albert Einstein College of Medicine, from which he received M.S., Ph.D., and M.D. degrees. He did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School and gained clinical experience at Massachusetts General and elsewhere.
I am grateful to the search committee, led by former Vice Chair of the University’s Board of Directors Howard J. Gray, S.J., for its efforts over the course of the past months to ensure our ability to recruit a truly outstanding permanent leader for the Medical Center. I also wish to express my deep appreciation to Stuart Bondurant, M.D., who has provided generous, exceptional leadership as Interim Executive Vice President for Health Sciences and has become a truly integral member of the Georgetown community. We have been fortunate to have the wisdom and leadership of such a deeply respected figure in academic medicine at a crucial time at the Medical Center.
I very much look forward to introducing Dr. Federoff to the Medical Center community next week at a town hall meeting to be held on Wednesday, December 6 at 5 p.m. in the New Research Building Auditorium, and to introducing him to the wider University community in the months ahead. I also look forward to the vision he will bring to the Medical Center, enabling us to build in innovative ways on our 150-year tradition of excellence in medical education and on the significant momentum we have gained in biomedical research in recent decades.
You have my very best wishes.
Sincerely,
John J. DeGioia
The Georgetown University Community
Ladies and Gentlemen:
With great pleasure, I write to announce the appointment of Howard J. Federoff, M.D., Ph.D., as Executive Vice President for Health Sciences and Executive Dean of the School of Medicine, effective April 1, 2007. Dr. Federoff will be a frequent presence on campus over the course of the coming months, immersing himself in the transition to ensure that he is well acquainted with the Medical Center community and Medical Center operations and in a position to offer the most effective leadership possible when his term formally begins.
Dr. Federoff currently holds appointments as Senior Associate Dean for Basic Research; Professor of Neurology, Medicine, Microbiology, and Immunology; and Professor of Oncology and Genetics at the University of Rochester School of Medicine, and as Founding Director of the Center for Aging and Development Biology at the Aab Institute of Biomedical Sciences at Rochester. Since joining the Rochester faculty in 1995, he has also served as Director of the University of Rochester’s Interdepartmental Neuroscience Program and as Founding Chief of the Division of Molecular Medicine and Gene Therapy. His research interests include gene therapy and neurodegenerative diseases, and he holds a number of medical patents with a number of other patents pending. He brings to our community a strong record of leadership in academic medicine and achievement in biomedical research and an imaginative vision for the future of medical education and research at Georgetown—in traditional areas of strength and in the possibilities for interdisciplinary collaboration, translational research, and building further synergies with our clinical partner, MedStar Health, Inc.
Dr. Federoff is a highly regarded scientist, whose research has received support from the National Science Foundation, the National Institutes of Health (NIH), the Canadian MRC Centers of Excellence Program in Neuroscience, and the U.S. Department of Defense, among other sources. He has published widely in peer-reviewed journals and currently serves on the editorial boards of five such journals, including Brain and Mind, Experimental Neurology, and Gene Therapy. Earlier this year the NIH named Dr. Federoff Chair of the Recombinant DNA Advisory Committee. Before joining the Rochester community, he was Associate Professor of Medicine and Neuroscience at Albert Einstein College of Medicine, from which he received M.S., Ph.D., and M.D. degrees. He did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School and gained clinical experience at Massachusetts General and elsewhere.
I am grateful to the search committee, led by former Vice Chair of the University’s Board of Directors Howard J. Gray, S.J., for its efforts over the course of the past months to ensure our ability to recruit a truly outstanding permanent leader for the Medical Center. I also wish to express my deep appreciation to Stuart Bondurant, M.D., who has provided generous, exceptional leadership as Interim Executive Vice President for Health Sciences and has become a truly integral member of the Georgetown community. We have been fortunate to have the wisdom and leadership of such a deeply respected figure in academic medicine at a crucial time at the Medical Center.
I very much look forward to introducing Dr. Federoff to the Medical Center community next week at a town hall meeting to be held on Wednesday, December 6 at 5 p.m. in the New Research Building Auditorium, and to introducing him to the wider University community in the months ahead. I also look forward to the vision he will bring to the Medical Center, enabling us to build in innovative ways on our 150-year tradition of excellence in medical education and on the significant momentum we have gained in biomedical research in recent decades.
You have my very best wishes.
Sincerely,
John J. DeGioia